Bioceltix S.A. Logo

Bioceltix S.A. (BCX)

GPW

Currency in PLN
80.00
-0.90 (-1.11%)

Real-time Data

07:00 AM

Day's Range

79.10
80.90

52 wk Range

70.00
108.00

Profile - BCX - Bioceltix S.A.

Profile

Mic Code

XWAR

Sector

Healthcare

Industry

Biotechnology

Employees

41


Bioceltix S.A. is a biotechnology company focused on developing and commercializing innovative veterinary biomedicines. Its primary function is to enhance animal health through products designed for companion animals and livestock. Leveraging advancements in cell therapy and biologics, Bioceltix aims to address unmet medical needs in veterinary medicine by advancing treatments for conditions that go beyond traditional pharmaceuticals. The company's portfolio includes therapies targeting chronic and degenerative diseases, as well as skin conditions and other ailments in animals. Bioceltix's work is integral to sectors such as agriculture, pet care, and veterinary services, providing solutions that improve animal welfare and productivity. The company’s commitment to advancing veterinary care through science positions it as a key player in a niche, yet rapidly growing, segment of the global biotechnology market.

Profile Details

Type

Common Stock

Ceo

Mr. Lukasz Bzdzion

Address

Building III

City

Wroclaw

Zip

51-317

Country

Poland

Phone

48 71 880 8771

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.